Article

Association of Antihypertensive Medication and Steatotic Liver Disease with Liver Fibrosis and Mortality among US Adults

2025-05-21

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> Metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertension frequently coexist in adults across the Americas, yet evidence to guide pharmacologic management in individuals with both conditions remains limited. Antihypertensive medications may influence liver outcomes, but comparative data across drug classes are sparse. <h4>Methods</h4> We performed a c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ba44a5d0-97d3-5930-a580-b1c15e3dead4
DOI: 10.1101/2025.05.20.25328037

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Association of Antihypertensive Medication and Steatotic Liver Disease with Liver Fibrosis and Mortality among US AdultsDOI 10.1101/2025.05.20.25328037Read

Epidemiology, temporal trends, and fibrosis risk stratification in metabolic dysfunction-associated steatotic liver disease in UK primary care: a population-based cohort and nested case-control studySemantic proximity Read

Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol‑related liver disease represent distinct clinical phenotypes and fibrosis risks: insights from a population-based Polish cohort.Semantic proximity Read

The Effect of Cardiometabolic Drugs on Non-Alcoholic Fatty Liver Disease (NAFLD), Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Semantic proximity Read

Current Insights into Liver Fibrosis: Epidemiological Patterns, Etiopathogenesis, Clinical Correlates, and Research AgendaSemantic proximity Read

Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationSemantic proximity Read

Unveiling the Burden of MASLD and Liver Fibrosis in India: Novel Insights from the Phenome India Study into fibrosis without MASLDSemantic proximity Read

Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population.Semantic proximity Read

Age-stratified Analysis of Associations Between Participant’s Characteristics and NAFLDSemantic proximity Read

Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.Semantic proximity Read

Molecular characterization of liver steatosis through circulating proteins, metabolites and lipidsSemantic proximity Read

Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine.Semantic proximity Read

Prevalence of Significant and Advanced Hepatic Fibrosis in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)Semantic proximity Read